Evidence map›Paper›PMID 24838502›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2014

Overexpression of angiotensin-converting enzyme 2 attenuates tonically active glutamatergic input to the rostral ventrolateral medulla in hypertensive rats.

Yang-Kai Wang, Du Shen, Qiang Hao, Qiang Yu, Zhao-Tang Wu, Yu Deng, Yan-Fang Chen, Wen-Jun Yuan, Qi-Kuan Hu, Ding-Feng Su and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients.Hypertension research : official journal of the Japanese Society of Hypertension · 2022
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Yang-Kai WangDepartment of Physiology, Second Military Medical University, Shanghai, China;
Du ShenDepartment of Physiology, Second Military Medical University, Shanghai, China;
Qiang HaoDepartment of Medical Imaging, Changhai Hospital, Shanghai, China;
Qiang YuDepartment of Neurobiology and Physiology, Ningxia Medical University, Yinchuan, China; and.
Zhao-Tang WuDepartment of Physiology, Second Military Medical University, Shanghai, China;
Yu DengDepartment of Neurobiology and Physiology, Ningxia Medical University, Yinchuan, China; and.
Yan-Fang ChenDepartment of Pharmacology and Toxicology, Wright State University School of Medicine, Dayton, Ohio.
Wen-Jun YuanDepartment of Neurobiology and Physiology, Ningxia Medical University, Yinchuan, China; and.
Qi-Kuan HuDepartment of Neurobiology and Physiology, Ningxia Medical University, Yinchuan, China; and.
Ding-Feng SuDepartment of Physiology, Second Military Medical University, Shanghai, China;
Wei-Zhong WangDepartment of Physiology, Second Military Medical University, Shanghai, China; wangwz68@hotmail.com.
Second Military Medical University · CNNingxia Medical University · CNChanghai Hospital · CNWright State University · US

Funding

Balance of Angiotensin II/Angiotensin (1-1): A Target in Ischemic StrokeR01HL098637 · NHLBI · WRIGHT STATE UNIVERSITY · PI CHEN, YANFANG · 2010 to 2013
$1.4M
NHLBI NIH HHS HL-098637
6 · The paper itself

Abstract

The rostral ventrolateral medulla (RVLM) plays a key role in cardiovascular regulation. It has been reported that tonically active glutamatergic input to the RVLM is increased in hypertensive rats, whereas angiotensin-converting enzyme 2 (ACE2) in the brain has been suggested to be beneficial to hypertension. This study was designed to determine the effect of ACE2 gene transfer into the RVLM on tonically active glutamatergic input in spontaneously hypertensive rats (SHRs). Lentiviral particles containing enhanced green fluorescent protein (lenti-GFP) or ACE2 (lenti-ACE2) were injected bilaterally into the RVLM. Both protein expression and activity of ACE2 in the RVLM were increased in SHRs after overexpression of ACE2. A significant reduction in blood pressure and heart rate in SHRs was observed 6 wk after lenti-ACE2 injected into the RVLM. The concentration of glutamate in microdialysis fluid from the RVLM was significantly reduced by an average of 61% in SHRs with lenti-ACE2 compared with lenti-GFP. ACE2 overexpression significantly attenuated the decrease in blood pressure and renal sympathetic nerve activity evoked by bilateral injection of the glutamate receptor antagonist kynurenic acid (2.7 nmol in 100 nl) into the RVLM in SHRs. Therefore, we suggest that ACE2 overexpression in the RVLM attenuates the enhanced tonically active glutamatergic input in SHRs, which may be an important mechanism underlying the beneficial effect of central ACE2 to hypertension.

Indexed as

Angiotensin-Converting Enzyme 2AnimalsBlood PressureDisease Models, AnimalExcitatory Amino Acid AntagonistsGenetic VectorsGene Transfer TechniquesGlutamic AcidGreen Fluorescent ProteinsHeart RateHumansHypertensionInjectionsKynurenic AcidLentivirusMaleACE2 protein, humanAce2 protein, ratAngiotensin-Converting Enzyme 2enhanced green fluorescent proteinExcitatory Amino Acid AntagonistsGlutamic AcidGreen Fluorescent ProteinsKynurenic AcidNorepinephrinePeptidyl-Dipeptidase AReceptors, Glutamategene transferglutamatehypertensionrenin-angiotensin systemsympathetic activity

Identifiers

PMID24838502
PMCPMC4101646
OpenAlexW2126754451

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.